These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9210004)

  • 61. Helicobacter pylori: related to rosacea?
    Grilli R
    J Am Acad Dermatol; 2000 Mar; 42(3):536-7. PubMed ID: 10688738
    [No Abstract]   [Full Text] [Related]  

  • 62. Anti-helicobacter regimens.
    Harris A; Misiewicz JJ
    Lancet; 1996 Apr; 347(9009):1193-4. PubMed ID: 8609799
    [No Abstract]   [Full Text] [Related]  

  • 63. Colloidal bismuth subcitrate in peptic ulcer--a review.
    Tytgat GN
    Digestion; 1987; 37 Suppl 2():31-41. PubMed ID: 3305117
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synergism between clindamycin and colloidal bismuth subcitrate against Helicobacter (Campylobacter) pylori in vitro.
    Vogt K; Hahn H
    Zentralbl Bakteriol; 1990 Nov; 274(2):246-9. PubMed ID: 2085373
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination treatment: colloidal bismuth subcitrate with H2-antagonists.
    Salmon PR
    Digestion; 1987; 37 Suppl 2():42-6. PubMed ID: 2887475
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Helicobacter pylori and non-ulcer dyspepsia.
    Laine L
    Gastroenterology; 1992 Jul; 103(1):340-1. PubMed ID: 1612344
    [No Abstract]   [Full Text] [Related]  

  • 67. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.
    Miller JP; Faragher EB
    Scand J Gastroenterol Suppl; 1989; 160():39-45. PubMed ID: 2573145
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-helicobacter regimens.
    Savarino V; Mela GS; Vigneri S; Celle G
    Lancet; 1996 Apr; 347(9009):1194. PubMed ID: 8609801
    [No Abstract]   [Full Text] [Related]  

  • 69. Helicobacter pylori positive resistant duodenal ulcers.
    Moran A; Panos MZ; Asquith P
    Gut; 1993 Nov; 34(11):1647; author reply 1647-8. PubMed ID: 8244160
    [No Abstract]   [Full Text] [Related]  

  • 70. Bismuth salts and neurotoxicity. A randomised, single-blind and controlled study.
    Noach LA; Eekhof JL; Bour LJ; Posthumus Meyjes FE; Tytgat GN; Ongerboer de Visser BW
    Hum Exp Toxicol; 1995 Apr; 14(4):349-55. PubMed ID: 7598995
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anti-Helicobacter pylori agents endowed with H2-antagonist properties.
    Sorba G; Bertinaria M; Di Stilo A; Gasco A; Scaltrito MM; Brenciaglia MI; Dubini F
    Bioorg Med Chem Lett; 2001 Feb; 11(3):403-6. PubMed ID: 11212121
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.
    Vogt K; Rodloff AC; Hahn H
    Infection; 1991; 19(3):138-9. PubMed ID: 1832417
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gastroprotective effect of MX1 (a novel salt of the active metabolite of roxatidine with a complex of bismuth and citric acid) against stress ulcers in rats.
    Marazova K; Klouchek E; Popov A; Ivanov CH; Krushkov I
    J Pharm Pharmacol; 1997 Aug; 49(8):791-5. PubMed ID: 9379358
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori.
    Ge R; Sun X; Gu Q; Watt RM; Tanner JA; Wong BC; Xia HH; Huang JD; He QY; Sun H
    J Biol Inorg Chem; 2007 Aug; 12(6):831-42. PubMed ID: 17503094
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Conservative treatment of patients with stomach polyps].
    Vakhrushev IaM; Kniazeva BG
    Eksp Klin Gastroenterol; 2002; (4):44-6. PubMed ID: 12503275
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studies on the mechanism of action of colloidal bismuth subcitrate. I. Interaction with sulfhydryls.
    Beil W; Bierbaum S; Sewing KF
    Pharmacology; 1993 Aug; 47(2):135-40. PubMed ID: 8395060
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New drugs: retapamulin, bismuth subcitrate potassium, and rotigotine.
    Hussar DA
    J Am Pharm Assoc (2003); 2007; 47(4):539-43. PubMed ID: 17616504
    [No Abstract]   [Full Text] [Related]  

  • 78. Metronidazole susceptibility in Helicobacter pylori.
    Van der Wouden EJ; Thijs JC; Van Zwet AA
    Gastroenterology; 1999 Oct; 117(4):1032-3. PubMed ID: 10576979
    [No Abstract]   [Full Text] [Related]  

  • 79. Helicobacter pylori infection in dialyzed patients: bismuth therapy and pharmacokinetics.
    Treiber G; Gadziwa U; Klotz U
    Nephron; 1992; 61(2):227. PubMed ID: 1630551
    [No Abstract]   [Full Text] [Related]  

  • 80. 1976 and all that!--20 years of antisecretory therapy.
    Garner A; Fadlallah H; Parsons ME
    Gut; 1996 Dec; 39(6):784-6. PubMed ID: 9038657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.